The recent announcement by 23andMe, stating it now has FDA authorization to report on three specific BRCA1 and BRCA2 breast cancer gene mutations associated with breast, ovarian and prostate cancer via direct-to-consumer (DTC) testing, stirred up debate. Since reading about this announcement, I’ve been mulling over my thoughts on it.
BRCA
One of the first thoughts that crossed my mind when we ushered in 2018, was gosh, it’s ten years since Mother died. Ten years. A whole decade. One-tenth of a century. 120 months. 520 weeks. 3,650 days. That old cliche, it still feels like yesterday fits. So does that other one, it seems like a …
When your cancer experience feels marginalized — have you experienced this? Not a good feeling is it? A topic that often comes up in emails I receive from readers and in Facebook groups I’m in is this one — feeling marginalized, regarding your cancer experience. This can happen regardless of stage, by the way. Have …
Are you feeling confused by the recently implemented updates to the breast cancer staging system? Did you even know changes have been made? I only learned about the changes late last year, and I have been trying to figure out what the changes mean. This post is my attempt to share some of what I …
Most breast cancers are not hereditary, but rather are considered sporadic. The latter is not the case in my family. When hereditary cancer impacts YOUR family, it’s a huge deal because suddenly, it’s not just about you. If you’ve been reading Nancy’s Point for a while, you know I generally don’t talk about my family …